Full-Year Adjusted EBITDA and Margin Improvement
Full-year adjusted EBITDA of EUR 1,444 million (adjusted for FX translation and India divestment), within ~1% of constant-currency guidance; full-year profitability (adjusted EBITDA margin) 14.2%, up 40 basis points versus prior year.
Strong Q4 EBITDA and Margin Expansion
Q4 adjusted EBITDA of EUR 309 million (EUR 343 million at constant currencies and adjusted for India), a comparable increase of ~7% year-on-year; Q4 margin ~13%, up 70 basis points y/y.
Material Free Cash Flow and Deleveraging
FY free cash flow of EUR 606 million (Q4 free cash flow EUR 362 million); net debt reduced to below EUR 3 billion and leverage reduced to ~2x, aligned with midterm target.
Value-Creating India Divestment
Sale of Akzo Nobel India Limited for ~EUR 900 million at an attractive ~25x EBITDA multiple; retained powder business via minority buyout and secured recurring royalty stream from divested liquid coatings.
SG&A and Industrial Efficiency Delivery
SG&A program delivered gross cost savings of EUR 200 million (EUR 145 million achieved to date), eliminating ~2,900 functional positions and exceeding target by ~EUR 80 million; Industrial Excellence program on track (12 site closures to date) and expected to deliver total gross savings of EUR 300 million, with EUR 90 million benefit in 2026.
Aggregate Cost Takeout and 2026 EBITDA Upside Target
Combined self-help programs expected to deliver ~EUR 0.5 billion of gross cost savings; company targets at least EUR 100 million higher full-year adjusted EBITDA in 2026 on a comparable basis (driven largely by cost actions).
Operational Improvements in Working Capital and ROI
Trade working capital improved to 14.7% (1 percentage point improvement y/y) with DIO flat despite strategic prebuys; return on investment improved to 13.5% from 13.3%.
Strategic Merger with Axalta and Expected Synergies
Proposed merger of equals with Axalta progressing (regulatory filings being submitted); expects at least USD 600 million of cost synergies and revenue synergies of 100–200 basis points, with closing targeted late 2026/early 2027.